TE_15009
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L2, L2a_3end |
|---|---|
| TE superfamily | L2 |
| TE class | LINE |
| Gene | ARMC2 |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 0.05 |
| Counts of samples | TCGA_tumor:62; TCGA_normal:13; GTEx:1326 |
| TSS | chr6(+):108960901 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_15009.1 | ARMC2 | Chimeric | Non-coding | Non-coding | chr6(+):108960902,108960927,108961572,108961694,108962014,108962127,108964180,108964312,108964980,108965140,108973357,108973377 |
| teRNA_15009.2 | ARMC2 | Chimeric | Non-coding | Non-coding | chr6(+):108960902,108960927,108961572,108961694,108962014,108962127,108964180,108964312,108964980,108965000 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
